Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a minor deployment update to the page. This update does not alter the study details or other content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, indicating a new build/maintenance update of the ClinicalTrials.gov page. This update does not alter the study content or data displayed.SummaryDifference0.1%

- Check51 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, indicating a minor page update. No study information or functionality is affected.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software/system update for the page.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a Revision: v3.6.0 notice. The 'Intervention / Treatment' label was reformatted to 'Intervention/Treatment' and the older 'Revision: v3.5.5' note was removed.SummaryDifference0.5%

- Check80 days agoChange DetectedA new page revision tag v3.5.5 has been added, replacing the previous v3.5.4 to reflect an update to the page's documentation/UI.SummaryDifference0.1%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.